# ESOMEPRAZOLE MAGNESIUM
> **ANDA212507** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2020-06-02
## Drug
- **FDA Application Number:** ANDA212507
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ESOMEPRAZOLE MAGNESIUM
- **Generic name:** ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE
- **Active ingredients:** ESOMEPRAZOLE MAGNESIUM
- **Dosage form:** CAPSULE, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** HETERO LABS LTD III
- **Manufacturer:** Allegiant Health
- **First approval:** 2020-06-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212507)
---
*AI Analytics · CC0 1.0*